[
  {
    "ts": null,
    "headline": "Natera Shares Rise on the Launch of AI Platform for Precision Oncology",
    "summary": "NTRA shares gain after unveiling its in-house AI platform, built on vast oncology datasets to transform precision cancer care.",
    "url": "https://finnhub.io/api/news?id=015b032fefd112a3857515fd18df6f693b0c19d49565184a5d321bdd1cd17455",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1756140720,
      "headline": "Natera Shares Rise on the Launch of AI Platform for Precision Oncology",
      "id": 136522512,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "WST",
      "source": "Yahoo",
      "summary": "NTRA shares gain after unveiling its in-house AI platform, built on vast oncology datasets to transform precision cancer care.",
      "url": "https://finnhub.io/api/news?id=015b032fefd112a3857515fd18df6f693b0c19d49565184a5d321bdd1cd17455"
    }
  },
  {
    "ts": null,
    "headline": "Q2 Earnings Recap: West Pharmaceutical Services (NYSE:WST) Tops Drug Development Inputs & Services Stocks",
    "summary": "As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results from Q2. Today, we are looking at drug development inputs & services stocks, starting with West Pharmaceutical Services (NYSE:WST).",
    "url": "https://finnhub.io/api/news?id=0c664c574f923b73b7636dfbe1e0a831b36610aac0215325e523350f5e89182d",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1756092749,
      "headline": "Q2 Earnings Recap: West Pharmaceutical Services (NYSE:WST) Tops Drug Development Inputs & Services Stocks",
      "id": 136522797,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "WST",
      "source": "Yahoo",
      "summary": "As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results from Q2. Today, we are looking at drug development inputs & services stocks, starting with West Pharmaceutical Services (NYSE:WST).",
      "url": "https://finnhub.io/api/news?id=0c664c574f923b73b7636dfbe1e0a831b36610aac0215325e523350f5e89182d"
    }
  }
]